Home / Immunoglobulins, Normal Human, for Intravascular Adm. / Belgium
BE ATC J06BA02 · updated 2 Nov 2026
Immunoglobulins, Normal Human, for Intravascular Adm. shortage in Belgium
Is there an Immunoglobulins, Normal Human, for Intravascular Adm. shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Immunoglobulins, Normal Human, for Intravascular Adm. product is reported short in Belgium, the first since 1 Jan 2020. The company estimate for the return is 30 Sep 2030. Main reason: other.
Also short in Italy, Spain, Austria, Switzerland, Sweden. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Panzyga 100 mg/ml inf. sol. i.v. vial 100 ml | Octapharma Benelux | 1 Jan 2020 | 30 Sep 2030 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.